Targeted treatment for amyloidosis

Isr Med Assoc J. 2014 May;16(5):277-80.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amyloid* / classification
  • Amyloid* / metabolism
  • Amyloidosis* / drug therapy
  • Amyloidosis* / etiology
  • Amyloidosis* / metabolism
  • Amyloidosis* / pathology
  • Carboxylic Acids / pharmacology*
  • Disease Management
  • Genetic Therapy
  • Humans
  • Molecular Targeted Therapy / methods
  • Plaque, Amyloid / metabolism
  • Plaque, Amyloid / pathology
  • Plaque, Amyloid / ultrastructure
  • Prealbumin / metabolism*
  • Protein Stability / drug effects
  • Pyrrolidines / pharmacology*
  • Sequestering Agents / pharmacology
  • Serum Amyloid A Protein / metabolism*
  • Serum Amyloid P-Component / metabolism

Substances

  • Amyloid
  • Carboxylic Acids
  • Prealbumin
  • Pyrrolidines
  • R-1-(6-(R-2-carboxypyrrolidin-1-yl)-6-oxohexanoyl)pyrrolidine-2-carboxylic acid
  • Sequestering Agents
  • Serum Amyloid A Protein
  • Serum Amyloid P-Component